Related by context. All words. (Click for frequent words.) 70 CYT# potent vascular disrupting 69 lymphomas leukemias 68 K ras mutations 67 HER2 expression 67 gastric carcinoma 67 hematological parameters 67 FGFs 67 selective modulator 67 relapsed MM 67 KRAS oncogene 67 hypereosinophilic syndrome 67 demonstrated antitumor activity 67 novel VDA molecule 66 TMPRSS2 ERG 66 cytokines chemokines 66 antimetabolites 66 lactate dehydrogenase LDH 66 HER2 overexpression 66 epithelial tumors 66 splice variants 66 ERK signaling 66 VIPR2 66 gene polymorphisms 66 p# biomarker 66 Cystatin C 65 chronic eosinophilic leukemia 65 cMET 65 kidney urologic 65 TMPRSS2 ERG fusion 65 Cathepsin B 65 potently inhibited 65 Clusterin 65 inducible nitric oxide synthase 65 miRNA expression 65 Upregulation 65 Thalomid ® 65 squamous cell lung cancer 65 MAPK pathway 65 BRAF V#E 65 missense mutations 65 Myelodysplastic syndromes MDS 65 haematologic 65 mesangial 65 pancreatic endocrine 65 CTAP# Capsules 65 inflammatory biomarkers 65 histologic subtype 65 polycythemia vera PV 65 CYP#A# CYP#D# 65 PIK3CA 65 orally administered inhibitor 65 Leukemias 65 Cytogenetic 65 receptor tyrosine kinase inhibitor 65 Tasigna prolongs 65 left ventricular diastolic 65 pancreatic prostate 65 papillary renal cell carcinoma 65 mutated K ras 65 Evoltra ® 65 myopathies 65 taxane resistant 65 TNFalpha 65 unresectable tumors 64 methylation markers 64 p# alpha [001] 64 skeletal metastases 64 redox active 64 CD#c 64 somatostatin 64 Fibroblast 64 urothelial 64 Factor Receptor 64 AGTR1 64 hypermethylated 64 hormone receptor status 64 HIV HCV coinfected 64 T1DM 64 antisense inhibition 64 pathophysiological effects 64 bronchoalveolar lavage fluid 64 metaplasia 64 #T# L1 64 antiangiogenic activity 64 monogenic 64 #beta HSD1 64 peripheral blood mononuclear 64 HER2 positive cancers 64 thyroid carcinoma 64 lymphoblasts 64 1 diabetes T1D 64 K ras 64 Treg cell 64 myeloproliferative diseases 64 metastatic neuroendocrine tumors 64 serum BDNF 64 myelodysplastic myeloproliferative diseases 64 ABCB1 64 pulmonary metastases 64 Haptoglobin 64 mda 7 64 chemosensitivity 64 Jhdm2a 64 p# activation 64 clinicopathological 64 Microalbuminuria 64 radiosensitivity 64 normal karyotype 64 cisplatin resistant 64 isotypes 64 pleiotropic effects 64 serum lipid 64 pretransplant 64 osteosarcomas 64 glial tumors 64 ovarian carcinoma 64 microRNA expression 64 tubulin inhibitor 64 ultrastructural 64 tryptase 64 RRM1 64 carotid plaque 63 reversible inhibitor 63 plasma lipid 63 haematopoietic stem cell 63 prognostically 63 leukemia multiple myeloma 63 immunohistochemical 63 inhibin B 63 Histologic 63 Macrophage 63 perineural invasion 63 extramedullary 63 renal cortical 63 TMEM#B 63 haematopoietic 63 fusion enhancers 63 LHRH receptor positive 63 Gleevec resistant 63 diagnostic biomarker 63 Pancreatic neuroendocrine tumors 63 hepatic enzymes 63 pharmacodynamic markers 63 Her2/neu 63 proton MR spectroscopy 63 relapsed ALL 63 Cyclin E 63 anterior pituitary 63 CD# + [001] 63 reduce serum phosphate 63 prognostic markers 63 carcinoembryonic antigen 63 SGPT 63 Ribavirin causes 63 JAK2 enzyme 63 cause cardiac channelopathies 63 Apolipoprotein B 63 KCNH2 63 Hp2 2 63 antiproliferative effects 63 TÎ ² 4 63 potent inducer 63 MCSP respectively 63 methylation patterns 63 gene rearrangements 63 HbF 63 TOP2A 63 PBMCs 63 lactate dehydrogenase 63 mRNA expression 63 hyperphenylalaninemia HPA due 63 LRP5 63 endocrine therapies 63 hematologic parameters 63 pharmacodynamic parameters 63 abnormal glucose metabolism 63 HepG2 cells 63 completely resected 63 circadian genes 63 allogeneic HSCT 63 Polymorphisms 63 oral picoplatin 63 γ secretase 63 pancreatic lung 63 glutamic acid decarboxylase 63 DNA methylation patterns 63 BCL#A 63 constitutively expressed 63 PLX STROKE targeting 63 mediated inhibition 63 Immunotherapeutic 63 lipoprotein metabolism 63 xenograft models 63 Ph + acute lymphoblastic 63 Elevated serum 63 retinal ischemia 63 IL 1ß 63 KRAS mutation 63 susceptibility loci 63 TXNIP 63 transgenic rats 63 fibrin deposition 63 eosinophil count 63 ovarian pancreatic 63 coagulation disorders 63 Histological 63 vestibular schwannomas 63 plasma pharmacokinetics 63 hematopoietic cancers 63 IgG4 63 Th2 cytokines 63 mTOR inhibitors 63 nonnucleoside reverse transcriptase inhibitors 63 prospectively stratified 63 immune modulating 63 adipogenic 63 hematopoietic progenitor cells 63 protein tyrosine phosphatase 1B 63 chromosomal anomalies 63 Mesenchymal 63 GH deficiency 63 transgenic mouse models 63 gastrointestinal stromal tumors GISTs 63 renal cell carcinomas 63 plasmacytoid 63 Vidaza ® 63 Colon polyps 63 ADPKD 63 antiangiogenic drugs 63 hepatocellular carcinomas 63 neovasculature 62 aminotransferase 62 proto oncogene 62 metabolite concentrations 62 Transcriptome 62 breast cancer subtypes 62 pathological hallmark 62 serum phosphate 62 lesional 62 TPMT 62 myelofibrosis polycythemia vera 62 receptor inhibitor 62 Lp PLA 2 62 demyelinating 62 Histopathological 62 myeloperoxidase 62 syngeneic 62 neuronal dysfunction 62 essential thrombocythemia 62 interleukin IL -# 62 Darapladib 62 lymphoid tumors 62 microsatellite instability 62 suppresses tumor 62 prospective multicentre 62 invasive lobular 62 PARP inhibition 62 pleiotropic 62 MGd 62 CYP#A# substrate 62 selectively inhibited 62 immunohistochemical analysis 62 VKORC1 62 GRNCM1 62 Darinaparsin 62 Tr DNA 62 C1 INH deficiency 62 enzyme immunoassay EIA 62 Estrogen Receptor 62 dyskeratosis congenita 62 hyaluronidase enzyme 62 riociguat 62 IMiDs ® 62 antibody mediated 62 monocyte chemoattractant protein 62 stratifying patients 62 nonbacterial prostatitis 62 aMCI precursor 62 urate levels 62 aspartate aminotransferase AST 62 chemoresistant 62 intestinal permeability 62 renal cysts 62 baseline LDH 62 fibrotic disease 62 intact parathyroid hormone 62 MLL2 62 colorectal adenoma 62 prognostic biomarker 62 metabolic parameters 62 bladder ovarian 62 endothelial activation 62 Vidofludimus 62 diabetic kidney 62 specific antigen PSA 62 liver metastasis 62 leiomyomas 62 poor metabolizers 62 DNA rearrangements 62 microsomal 62 prognostic indicators 62 serous ovarian cancer 62 Fc receptor 62 activated microglia 62 XL# inhibits 62 epithelial tissues 62 hyperplastic 62 Shows Promise Against 62 potently inhibit 62 HuCNS SC ® 62 ALN TTR 62 triacylglycerol concentrations 62 CYP#C# [002] 62 leukocyte adhesion 62 histologic subtypes 62 tumor xenograft models 62 tumor subtypes 62 sitosterol 62 secretory phospholipase A2 sPLA2 62 motor neuron degeneration 62 Pegylated 62 seminomas 62 transthyretin TTR 62 genomic biomarker 62 AAG geldanamycin analog 62 GPC5 62 clinicopathologic 62 Prolongs Survival 62 Phase #/#a trial 62 haematological 62 hCG Beta 62 hematological diseases 62 Leydig cell 62 clinico pathological 62 Mutational 62 promoter hypermethylation 62 subependymal giant cell 62 receptor subtypes 62 Hematopoietic 62 Antitumor 62 Epstein Barr Virus EBV 62 number NCT# ClinicalTrials.gov 62 Epidermal Growth Factor Receptor 62 polycythemia vera essential thrombocythemia 62 elevated triglyceride levels 62 Angiotensin converting enzyme 62 castrate resistant 62 hamartomas 62 familial clustering 62 hepatoma 62 prostate carcinoma 62 LDL particle 62 cathepsins 62 inverse agonist 62 airway hyperresponsiveness 62 leukocyte counts 62 osteoprotegerin 62 nonalcoholic steatohepatitis NASH 62 colorectal liver metastases 62 molecular biomarker 62 colorectal carcinogenesis 62 FUS1 62 NPM1 mutations 62 #q# deletion 62 mTOR mammalian target 62 ORMDL3 62 hypomethylation 62 breast carcinoma 62 prostate carcinogenesis 62 tumorigenicity 62 Dysregulation 62 histone deacetylase HDAC 62 prostate cancer CaP 62 APOL1 62 haematologic malignancies 62 flavopiridol 62 Epigenomics proprietary 62 nonhereditary 61 abnormal p# 61 urine cytology 61 MTHFD1L gene 61 Letairis ambrisentan 61 BRAF gene mutations 61 ATTR CM 61 epoetin alpha 61 HIF 1alpha 61 lung pancreatic 61 heavily pretreated 61 MAGE A3 ASCI 61 pancreatic islet cell 61 pharmacodynamic biomarkers 61 albumin excretion 61 neurite outgrowth 61 CC genotype 61 factor TNF 61 Endothelial dysfunction 61 p# MAPK 61 GSTP1 61 intestinal mucosal 61 PNH patients 61 ERalpha 61 Papillary 61 impaired glucose metabolism 61 MetAP2 61 phenotypic expression 61 arterial thickening 61 molecular biomarkers 61 IGF IR 61 RQ PCR 61 Genetic variations 61 Hematologic 61 dasatinib Sprycel 61 Ki# 61 Genotypes 61 Adenomas 61 SSc 61 prostate abnormalities 61 kinase inhibition 61 recurrent glioblastoma multiforme 61 histological subtype 61 nonmetastatic 61 prognostic indicator 61 phylloquinone 61 Cytochrome P# 61 alpha7 61 transiently transfected 61 carcinoid 61 essential thrombocythemia ET 61 factor PlGF 61 NKX#.# 61 elevated uric acid 61 hypothalamic pituitary 61 KRAS mutant 61 telomerase inhibition 61 monocytes macrophages 61 Chlamydia trachomatis infection 61 Progenitor Cells 61 STRIDE PD 61 hepatorenal syndrome 61 transcriptional regulation 61 neuroinflammatory 61 esophageal carcinoma 61 colorectal polyp 61 tissue fibrosis 61 genetic loci 61 cytogenic 61 uricase 61 thyrotropin 61 receiving VELCADE 61 Primary endpoints 61 adrenocortical cancer 61 Enzastaurin 61 mitogenic 61 promoter methylation 61 gene polymorphism 61 immunoregulatory 61 neuritic 61 Kinoid 61 heparanase 61 alanine aminotransferase 61 artery elasticity 61 triglyceride concentrations 61 basal cell nevus syndrome 61 HIF 1α 61 Endometrial 61 cyclic AMP cAMP 61 Lymphoid 61 pharmacokinetic parameters 61 IL #p# 61 PIGF 61 candidates Azedra TM 61 Topoisomerase II 61 thalidomide Thalomid 61 TRAIL induced apoptosis 61 Kit CD# positive 61 deacetylase 61 Chronic lymphocytic leukemia 61 PDE1 61 Cardiotoxicity 61 PI3K/mTOR 61 A3 adenosine receptor 61 #ME# 61 advanced metastatic renal 61 ThermoDox ® clinical 61 lung carcinomas 61 VEGF expression 61 EGFR expression 61 bronchial epithelial cells 61 histologies 61 atherothrombosis 61 NPHP 61 microRNA molecules 61 electrophysiologic 61 glycosylated hemoglobin levels 61 antimitotic 61 Exacerbations 61 Fibroblast growth 61 4E BP1 61 non coding RNA 61 immunostaining 61 histone acetylation 61 antitumor efficacy 61 TTR amyloidosis 61 androgen independent 61 folate metabolism 61 neurosensory 61 benign neoplasms 61 MAGE A3 61 antiangiogenic agent 61 LH FSH 61 plasma lipoprotein 61 potent inhibitors 61 somatic mutations 61 myeloproliferative neoplasms MPNs 61 soluble CD# ligand 61 5 HT2A inverse 61 mGluR2 NAM 61 cystatin C 61 Parathyroid hormone 61 Allogeneic 61 breast carcinomas 61 thyroid stimulating hormone 61 pituitary adenomas 61 fructosamine 61 SORT OUT III 61 gastric cardia 61 neurocognitive function 61 arterial calcification 61 assay detects 61 lymphoproliferative disorders 61 pancreatic adenocarcinoma 61 allogeneic HCT 61 antiangiogenesis 61 hepatic enzyme 61 bFGF 61 Hypertrophy 61 cell adhesion molecule 61 methylenetetrahydrofolate reductase 61 serum creatinine levels 61 neovascularisation 61 adrenocortical 61 serum biomarkers 61 gene loci 61 Circulating tumor cells 61 OGG1 61 ENMD # 61 lymphoid malignancies 61 serum triglycerides 61 mechanistic studies 61 cells hESCs 61 refractory chronic lymphocytic 61 Carcinoid tumors 61 taxane refractory 61 deCODE AF TM 61 bladder carcinoma 61 ENPP1 61 adipokines 61 PDE#A 61 functional polymorphism 61 adenocarcinomas 61 metastatic colorectal 61 osteoblastic 61 glycosylated hemoglobin HbA1c 61 MSH2 61 isoenzyme 61 sunitinib Sutent 61 lymphoma subtypes 61 pharmacodynamic endpoints 61 atherosclerosis regression 61 angiotensin analog 61 neuropsychiatric diseases 61 carotid IMT 61 #S rRNA gene 61 Intravenous immunoglobulin 61 ALB # 61 epigenetic markers 61 basal cell carcinoma squamous 61 CCR9 61 PTPN# 61 Solazed TM 61 Achieves Primary Endpoint 61 echocardiographic parameters 61 anti fibrotic 61 Hyperlipidemia 61 shorter telomere length 61 serum lipid levels 61 somatostatin receptor 61 Nonalcoholic fatty liver 61 immunochemical fecal occult 61 Interferon Beta 61 myeloproliferative neoplasms 61 cytopathic 61 SLITRK1 61 Squamous 61 ERK1 2 61 urinary N telopeptide 61 FMR1 61 prasterone 61 substantially excreted 61 leukaemias 61 underwent surgical resection 61 inhibit platelet function 61 colorectal carcinoma 61 abdominal adiposity 60 HOMA IR 60 malignant lymphomas 60 plasma renin activity 60 IPAH 60 S. maltophilia 60 hepatic liver 60 medically inoperable 60 hMG 60 paroxysmal nocturnal hemoglobinuria 60 bile acid metabolism 60 samalizumab 60 Warfarin Coumadin 60 Tie2 60 glucagon receptor 60 serum PTH 60 bronchopulmonary dysplasia BPD 60 PDGFR 60 bronchoalveolar lavage 60 NB S# strontium malonate 60 mechanistic insights 60 HGPIN 60 circulating endothelial 60 plasma triglycerides 60 antiapoptotic 60 pancreatic alpha 60 pancreatic islet beta 60 granulocyte 60 biochemical abnormalities 60 Hypotension 60 Undesirable alterations 60 TOP2A gene 60 delipidation 60 PKCi 60 neuroendocrine cancers 60 oesophageal adenocarcinoma 60 colorectal gastric 60 urothelial cancer 60 mitogen activated protein kinases 60 mitochondrial metabolism 60 Zemplar Capsules 60 thyroglobulin 60 p#INK#a 60 Levels Linked 60 serum leptin 60 AtherOx 60 abnormal cytology 60 chronic idiopathic thrombocytopenic purpura 60 Granulocyte Colony Stimulating Factor 60 HLA DQ2 60 BEXXAR Therapeutic Regimen 60 Aromatase 60 IMiDs ® compound 60 R Saizen R 60 castrate resistant prostate cancer 60 sporadic ALS 60 microarray experiments 60 Acute myeloid leukemia AML 60 SFRP1 60 scintigraphic 60 upregulates 60 severe hypersensitivity reactions 60 cellularity 60 pancreatic islet 60 microRNAs miRNAs 60 testicular germ cell 60 differentiated thyroid 60 granulomatous 60 PTHrP 60 vaso occlusive crisis 60 metastatic malignant 60 immunomodulation 60 colorectal adenocarcinoma 60 lymphangiogenesis 60 histopathological 60 K RAS 60 pT2 60 thyrotropin levels 60 esophagus bladder 60 Androgen 60 apolipoprotein B 60 cytotoxic therapies 60 potently inhibits 60 deep venous thromboses 60 esophageal gastric 60 Acute myelogenous leukemia 60 Glucocorticoids 60 5alpha reductase 60 bronchoalveolar lavage BAL 60 inhibit angiogenesis 60 osteoblast 60 MGUS 60 TTR gene 60 ANCA associated 60 hormone receptor negative 60 Prognostic factors 60 prognostic marker 60 CP CPPS 60 ovarian breast 60 Acute myeloid leukemia 60 ImmuKnow 60 Immunohistochemical staining 60 TIMP 1 60 Systemic lupus erythematosus SLE 60 factor HGF 60 alkaline phosphatase ALP 60 CSF biomarkers 60 dose proportionality 60 obstructive coronary artery 60 druggable targets 60 miRNA molecules 60 intracranial atherosclerosis 60 nonmelanoma 60 plasma leptin 60 Akt activation 60 Oxidative damage 60 COX2 60 MMP2 60 topoisomerase II inhibitor 60 Tß4 60 intravesical therapy 60 abnormal lipid 60 certain protein tyrosine 60 Vascugel 60 nodal metastasis 60 E selectin 60 hypocalcaemia 60 spermidine 60 PI3K Akt 60 MLH1 60 vitamin B# folic acid 60 ALK mutations 60 BRCA1 BRCA2 60 bone marrow mesenchymal stem 60 PI3K AKT 60 inhibitory neurotransmitters 60 neoplastic 60 FasL 60 myeloid 60 coinfected patients 60 Magnesium deficiency 60 interferon γ 60 lipid lowering agents 60 alpha fetoprotein AFP 60 somatic mutation 60 eTag assays 60 retinoid X 60 Situ Hybridization 60 enzyme inhibition 60 causative mutations 60 Chronic ITP 60 MEK ERK 60 Beta catenin pathway 60 differentially expressed genes 60 Protein Kinase C 60 #F FDG PET 60 Recombinant Human 60 antiphospholipid syndrome 60 sarcomatoid 60 lymphocytosis 60 decompensated liver disease 60 EGFR HER2 60 GRNOPC1 contains 60 induce apoptosis 60 interleukin IL -6 60 immunoreactivity 60 experimental allergic encephalomyelitis 60 oxidative stress markers 60 Methotrexate MTX 60 vascular endothelial 60 beta1 integrin 60 carcinoids originate 60 paraneoplastic 60 VCAM 1 60 fosbretabulin 60 β blockers 60 alpha GAL 60 Oncogenic 60 immunotherapeutic approaches 60 secondary hyperparathyroidism 60 serum homocysteine 60 KRAS mutations 60 cAMP signaling 60 Peginterferon alfa 2b 60 rheumatoid arthritis psoriatic arthritis 60 Hepatocytes 60 biologic pathway 60 deCODE ProstateCancer TM 60 insulin signaling pathways 60 obstructive coronary 60 neural progenitor 60 alanine aminotransferase ALT 60 MTHFR 60 steroidogenic 60 precursor lesions 60 vascular reactivity 60 lipid elevations 60 FUSILEV enhances 60 mg/m2 cohort 60 Anthracycline 60 serum calcium levels 60 Valproic acid 60 LAB CGRP 60 psoriasis Crohn disease 60 BCR ABL mutations 60 leukocytosis 60 lipid parameters 60 anaphylactic reactions bronchospasm 60 cardio renal 60 Progenitor cells 60 potent suppressor 60 protein tyrosine phosphatases 60 lymphocyte counts 60 immunoreactive 60 CD# expression [001] 60 deCODE BreastCancer 60 subcellular compartments 60 anticancer activity 60 serine proteases 60 glomerular filtration rate 60 Abeta# 60 transplantation HSCT 60 tumoral 60 humanized therapeutic 60 hormone secretion 60 node metastases 60 elevated LDH 60 serum calcium 60 alkylating agent 60 Atypical Hemolytic Uremic Syndrome 60 biologic pathways 60 cardioprotective effects 60 metabolomic profiles 60 endometriosis ovarian cysts 60 TIMP 60 bardoxolone methyl 60 GSTT1 60 JAK inhibitors 60 Thiazolidinediones 60 CYP#D# genotype 60 PENNVAX ™ B 60 cerebral glucose metabolism 60 differential gene expression 60 rheumatoid arthritis inflammatory bowel 60 E#F# 60 Immunohistochemical analysis 60 pro angiogenic 60 Ischemic 60 CLA supplementation 60 Tumor Response 60 AST ALT 60 Univariate 60 potent antitumor activity 60 KRAS mutated 60 proapoptotic 60 FGFR4 60 SensoLyte ™ 60 gonococcal 60 serum retinol 60 hypermethylation 60 murine models 60 albumin excretion rate 60 thymidylate synthase TS 60 dopamine D2 receptor 60 adenomatous polyposis coli 60 myeloproliferative 60 refractory colorectal cancer 60 intravascular hemolysis 60 cardiac repolarization 60 resected tumors 60 cytologic 60 Renal Cell Carcinoma RCC 60 Subgroup analysis 60 induced tumor regression 60 p# Shc 60 hyperoxaluria 60 GBMs 60 multicentric 60 CD# expressing 60 blood coagulation disorders 60 aggressive systemic mastocytosis 60 serum urate levels 60 immunohistochemical staining 60 SYN# 60 NSCLC tumors 60 histone deacetylases 60 ERK pathway 60 alkaline phosphatase 60 Eosinophils 60 PSADT 60 adipose stem 60 DNA Methylation 60 Symadex 60 Refractory Hodgkin Lymphoma 60 primary hyperparathyroidism 60 messenger ribonucleic acid 60 paclitaxel cisplatin 60 telomere lengths 60 underlying vasculopathy 60 microdeletion 60 BRCA deficient 60 vWF 60 accumulate preferentially 60 potent antiproliferative 60 pheochromocytoma 60 maternally inherited 60 proinflammatory mediators 60 induced sputum 60 intracranial hemorrhage ICH 60 trial evaluating PRX# 60 lung cancer NSCLC 60 microvessel density 60 induce remission 60 5 HT1A receptor 60 unknown etiology 60 Src kinase 60 immunodeficiency disorders 60 carotid artery thickness 60 hyperuricaemia 60 mucinous 60 cutaneous T 60 RAF kinase VEGFR 60 amyloid deposition 60 miRs 60 adjuvant therapies 60 Osteopontin 60 serum albumin 60 paricalcitol 60 colonic mucosa 60 CCR5 delta# 60 clefting 60 fasting plasma 60 noninvasive outpatient 60 IL 6R 60 microglial activation 60 induces apoptosis 60 renal fibrosis 60 Histologically 60 pathogenic mutations 60 CanAg 60 extracellular dopamine 60 Mg Usa 59 florbetaben 59 oncologic diseases 59 AML MDS 59 gastric corpus 59 neuropathologic 59 discontinued Viread 59 elevated ALT 59 neurotrophic 59 histopathologic 59 posttranslational modifications 59 alkylating 59 VEGF inhibitors 59 CINQUIL 59 plasma lipids 59 endometrial hyperplasia 59 Heterozygous 59 serologic tests 59 transgene expression 59 directed radiotherapeutic antibody 59 Cholinesterase Inhibitors 59 HER2 amplification 59 pharmacodynamic effects 59 SETDB1 59 phosphorylated tau 59 Single Nucleotide Polymorphisms 59 #q#.# [001] 59 tigecycline 59 Interferon alpha 59 IFN gamma 59 gastric carcinogenesis 59 intercellular signaling 59 effector function 59 post translational modifications 59 TNF alpha selectively neutralizing 59 onset diabetes mellitus 59 CYP #A# 59 MPS IVA 59 congenital toxoplasmosis 59 glioblastoma tumors 59 coronary microvascular 59 FISH fluorescence 59 nonalcoholic steatohepatitis 59 BCL2 59 gene amplification 59 IFN γ 59 troponins 59 homocysteine concentrations 59 pDC 59 putative biomarkers 59 TNF Tumor Necrosis Factor 59 atherosclerotic cardiovascular 59 therapeutically beneficial 59 Alleles 59 phylogenetic analyzes